Tiny implant could ease glaucoma pressure
NCT ID NCT06176170
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new device called the VividWhite Glaucoma Implant, which is surgically placed in the eye to help lower pressure in people with glaucoma. Sixty-five participants will be followed for 12 months to see if the implant safely reduces eye pressure and lessens the need for medication. The goal is to offer a long-term treatment option for this common eye condition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
VividWhite Glaucoma Implant (VW-51) – a small device surgically placed in the eye to help drain fluid and lower pressure.
What this could lead to
If successful, this implant could provide a new way to control eye pressure and reduce the need for daily eye drops in people with glaucoma.
What could go wrong
This is a small, early-stage study with no comparison group, so results may not apply to everyone. The implant could cause side effects like infection or require additional surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cataract & Eye Surgery Centre
Doncaster East, Victoria, 3109, Australia
-
Cerulea Clinical Trials, Centre for Eye Research Australia
East Melbourne, Victoria, 3002, Australia
-
Eye Surgery Associates
Vermont South, Victoria, 3133, Australia
-
Flinders Medical Centre
Bedford Park, South Australia, 5042, Australia
-
Melbourne Eye Specialists
Fitzroy, Victoria, 3065, Australia
-
Sydney Eye Hospital
Sydney, New South Wales, 2000, Australia